List of Chapters/Sections(Table Of Content)
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global mRNA Treatment Market Size Analysis from 2022 to 2027
1.5.1 Global mRNA Treatment Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global mRNA Treatment Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global mRNA Treatment Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: mRNA Treatment Industry Impact
Chapter 2 Global mRNA Treatment Competition by Types, Applications, and Top Regions and Countries
2.1 Global mRNA Treatment (Volume and Value) by Type
2.1.1 Global mRNA Treatment Consumption and Market Share by Type (2016-2021)
2.1.2 Global mRNA Treatment Revenue and Market Share by Type (2016-2021)
2.2 Global mRNA Treatment (Volume and Value) by Application
2.2.1 Global mRNA Treatment Consumption and Market Share by Application (2016-2021)
2.2.2 Global mRNA Treatment Revenue and Market Share by Application (2016-2021)
2.3 Global mRNA Treatment (Volume and Value) by Regions
2.3.1 Global mRNA Treatment Consumption and Market Share by Regions (2016-2021)
2.3.2 Global mRNA Treatment Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global mRNA Treatment Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global mRNA Treatment Consumption by Regions (2016-2021)
4.2 North America mRNA Treatment Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia mRNA Treatment Sales, Consumption, Export, Import (2016-2021)
4.4 Europe mRNA Treatment Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia mRNA Treatment Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia mRNA Treatment Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East mRNA Treatment Sales, Consumption, Export, Import (2016-2021)
4.8 Africa mRNA Treatment Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania mRNA Treatment Sales, Consumption, Export, Import (2016-2021)
4.10 South America mRNA Treatment Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America mRNA Treatment Market Analysis
5.1 North America mRNA Treatment Consumption and Value Analysis
5.1.1 North America mRNA Treatment Market Under COVID-19
5.2 North America mRNA Treatment Consumption Volume by Types
5.3 North America mRNA Treatment Consumption Structure by Application
5.4 North America mRNA Treatment Consumption by Top Countries
5.4.1 United States mRNA Treatment Consumption Volume from 2016 to 2021
5.4.2 Canada mRNA Treatment Consumption Volume from 2016 to 2021
5.4.3 Mexico mRNA Treatment Consumption Volume from 2016 to 2021
Chapter 6 East Asia mRNA Treatment Market Analysis
6.1 East Asia mRNA Treatment Consumption and Value Analysis
6.1.1 East Asia mRNA Treatment Market Under COVID-19
6.2 East Asia mRNA Treatment Consumption Volume by Types
6.3 East Asia mRNA Treatment Consumption Structure by Application
6.4 East Asia mRNA Treatment Consumption by Top Countries
6.4.1 China mRNA Treatment Consumption Volume from 2016 to 2021
6.4.2 Japan mRNA Treatment Consumption Volume from 2016 to 2021
6.4.3 South Korea mRNA Treatment Consumption Volume from 2016 to 2021
Chapter 7 Europe mRNA Treatment Market Analysis
7.1 Europe mRNA Treatment Consumption and Value Analysis
7.1.1 Europe mRNA Treatment Market Under COVID-19
7.2 Europe mRNA Treatment Consumption Volume by Types
7.3 Europe mRNA Treatment Consumption Structure by Application
7.4 Europe mRNA Treatment Consumption by Top Countries
7.4.1 Germany mRNA Treatment Consumption Volume from 2016 to 2021
7.4.2 UK mRNA Treatment Consumption Volume from 2016 to 2021
7.4.3 France mRNA Treatment Consumption Volume from 2016 to 2021
7.4.4 Italy mRNA Treatment Consumption Volume from 2016 to 2021
7.4.5 Russia mRNA Treatment Consumption Volume from 2016 to 2021
7.4.6 Spain mRNA Treatment Consumption Volume from 2016 to 2021
7.4.7 Netherlands mRNA Treatment Consumption Volume from 2016 to 2021
7.4.8 Switzerland mRNA Treatment Consumption Volume from 2016 to 2021
7.4.9 Poland mRNA Treatment Consumption Volume from 2016 to 2021
Chapter 8 South Asia mRNA Treatment Market Analysis
8.1 South Asia mRNA Treatment Consumption and Value Analysis
8.1.1 South Asia mRNA Treatment Market Under COVID-19
8.2 South Asia mRNA Treatment Consumption Volume by Types
8.3 South Asia mRNA Treatment Consumption Structure by Application
8.4 South Asia mRNA Treatment Consumption by Top Countries
8.4.1 India mRNA Treatment Consumption Volume from 2016 to 2021
8.4.2 Pakistan mRNA Treatment Consumption Volume from 2016 to 2021
8.4.3 Bangladesh mRNA Treatment Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia mRNA Treatment Market Analysis
9.1 Southeast Asia mRNA Treatment Consumption and Value Analysis
9.1.1 Southeast Asia mRNA Treatment Market Under COVID-19
9.2 Southeast Asia mRNA Treatment Consumption Volume by Types
9.3 Southeast Asia mRNA Treatment Consumption Structure by Application
9.4 Southeast Asia mRNA Treatment Consumption by Top Countries
9.4.1 Indonesia mRNA Treatment Consumption Volume from 2016 to 2021
9.4.2 Thailand mRNA Treatment Consumption Volume from 2016 to 2021
9.4.3 Singapore mRNA Treatment Consumption Volume from 2016 to 2021
9.4.4 Malaysia mRNA Treatment Consumption Volume from 2016 to 2021
9.4.5 Philippines mRNA Treatment Consumption Volume from 2016 to 2021
9.4.6 Vietnam mRNA Treatment Consumption Volume from 2016 to 2021
9.4.7 Myanmar mRNA Treatment Consumption Volume from 2016 to 2021
Chapter 10 Middle East mRNA Treatment Market Analysis
10.1 Middle East mRNA Treatment Consumption and Value Analysis
10.1.1 Middle East mRNA Treatment Market Under COVID-19
10.2 Middle East mRNA Treatment Consumption Volume by Types
10.3 Middle East mRNA Treatment Consumption Structure by Application
10.4 Middle East mRNA Treatment Consumption by Top Countries
10.4.1 Turkey mRNA Treatment Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia mRNA Treatment Consumption Volume from 2016 to 2021
10.4.3 Iran mRNA Treatment Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates mRNA Treatment Consumption Volume from 2016 to 2021
10.4.5 Israel mRNA Treatment Consumption Volume from 2016 to 2021
10.4.6 Iraq mRNA Treatment Consumption Volume from 2016 to 2021
10.4.7 Qatar mRNA Treatment Consumption Volume from 2016 to 2021
10.4.8 Kuwait mRNA Treatment Consumption Volume from 2016 to 2021
10.4.9 Oman mRNA Treatment Consumption Volume from 2016 to 2021
Chapter 11 Africa mRNA Treatment Market Analysis
11.1 Africa mRNA Treatment Consumption and Value Analysis
11.1.1 Africa mRNA Treatment Market Under COVID-19
11.2 Africa mRNA Treatment Consumption Volume by Types
11.3 Africa mRNA Treatment Consumption Structure by Application
11.4 Africa mRNA Treatment Consumption by Top Countries
11.4.1 Nigeria mRNA Treatment Consumption Volume from 2016 to 2021
11.4.2 South Africa mRNA Treatment Consumption Volume from 2016 to 2021
11.4.3 Egypt mRNA Treatment Consumption Volume from 2016 to 2021
11.4.4 Algeria mRNA Treatment Consumption Volume from 2016 to 2021
11.4.5 Morocco mRNA Treatment Consumption Volume from 2016 to 2021
Chapter 12 Oceania mRNA Treatment Market Analysis
12.1 Oceania mRNA Treatment Consumption and Value Analysis
12.2 Oceania mRNA Treatment Consumption Volume by Types
12.3 Oceania mRNA Treatment Consumption Structure by Application
12.4 Oceania mRNA Treatment Consumption by Top Countries
12.4.1 Australia mRNA Treatment Consumption Volume from 2016 to 2021
12.4.2 New Zealand mRNA Treatment Consumption Volume from 2016 to 2021
Chapter 13 South America mRNA Treatment Market Analysis
13.1 South America mRNA Treatment Consumption and Value Analysis
13.1.1 South America mRNA Treatment Market Under COVID-19
13.2 South America mRNA Treatment Consumption Volume by Types
13.3 South America mRNA Treatment Consumption Structure by Application
13.4 South America mRNA Treatment Consumption Volume by Major Countries
13.4.1 Brazil mRNA Treatment Consumption Volume from 2016 to 2021
13.4.2 Argentina mRNA Treatment Consumption Volume from 2016 to 2021
13.4.3 Columbia mRNA Treatment Consumption Volume from 2016 to 2021
13.4.4 Chile mRNA Treatment Consumption Volume from 2016 to 2021
13.4.5 Venezuela mRNA Treatment Consumption Volume from 2016 to 2021
13.4.6 Peru mRNA Treatment Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico mRNA Treatment Consumption Volume from 2016 to 2021
13.4.8 Ecuador mRNA Treatment Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in mRNA Treatment Business
14.1 CureVac
14.1.1 CureVac Company Profile
14.1.2 CureVac mRNA Treatment Product Specification
14.1.3 CureVac mRNA Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Silence Therapeutics
14.2.1 Silence Therapeutics Company Profile
14.2.2 Silence Therapeutics mRNA Treatment Product Specification
14.2.3 Silence Therapeutics mRNA Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Sanofi (Translate Bio)
14.3.1 Sanofi (Translate Bio) Company Profile
14.3.2 Sanofi (Translate Bio) mRNA Treatment Product Specification
14.3.3 Sanofi (Translate Bio) mRNA Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Moderna
14.4.1 Moderna Company Profile
14.4.2 Moderna mRNA Treatment Product Specification
14.4.3 Moderna mRNA Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 RaNA Therapeutics
14.5.1 RaNA Therapeutics Company Profile
14.5.2 RaNA Therapeutics mRNA Treatment Product Specification
14.5.3 RaNA Therapeutics mRNA Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 BioNTech (Pfizer)
14.6.1 BioNTech (Pfizer) Company Profile
14.6.2 BioNTech (Pfizer) mRNA Treatment Product Specification
14.6.3 BioNTech (Pfizer) mRNA Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Kernal Biologics
14.7.1 Kernal Biologics Company Profile
14.7.2 Kernal Biologics mRNA Treatment Product Specification
14.7.3 Kernal Biologics mRNA Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Ethris (AstraZeneca)
14.8.1 Ethris (AstraZeneca) Company Profile
14.8.2 Ethris (AstraZeneca) mRNA Treatment Product Specification
14.8.3 Ethris (AstraZeneca) mRNA Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global mRNA Treatment Market Forecast (2022-2027)
15.1 Global mRNA Treatment Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global mRNA Treatment Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global mRNA Treatment Value and Growth Rate Forecast (2022-2027)
15.2 Global mRNA Treatment Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global mRNA Treatment Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global mRNA Treatment Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America mRNA Treatment Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia mRNA Treatment Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe mRNA Treatment Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia mRNA Treatment Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia mRNA Treatment Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East mRNA Treatment Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa mRNA Treatment Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania mRNA Treatment Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America mRNA Treatment Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global mRNA Treatment Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global mRNA Treatment Consumption Forecast by Type (2022-2027)
15.3.2 Global mRNA Treatment Revenue Forecast by Type (2022-2027)
15.3.3 Global mRNA Treatment Price Forecast by Type (2022-2027)
15.4 Global mRNA Treatment Consumption Volume Forecast by Application (2022-2027)
15.5 mRNA Treatment Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
